Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1998 Jan;66(1):272–279. doi: 10.1128/iai.66.1.272-279.1998

Mycoplasma pulmonis Inhibits Electrogenic Ion Transport across Murine Tracheal Epithelial Cell Monolayers

Linda C Lambert 1, Hoa Q Trummell 2, Ashvani Singh 2, Gail H Cassell 1, Robert J Bridges 2,*
PMCID: PMC107887  PMID: 9423868

Abstract

Murine chronic respiratory disease is characterized by persistent colonization of tracheal and bronchial epithelial cell surfaces by Mycoplasma pulmonis, submucosal and intraluminal immune and inflammatory cells, and altered airway activity. To determine the direct effect of M. pulmonis upon transepithelial ion transport in the absence of immune and inflammatory cell responses, primary mouse tracheal epithelial cell monolayers (MTEs) were apically infected and assayed in Ussing chambers. M. pulmonis-infected MTEs, but not those infected with a nonmurine mycoplasma, demonstrated reductions in amiloride-sensitive Na+ absorption, cyclic AMP, and cholinergic-stimulated Cl secretion and transepithelial resistance. These effects were shown to require interaction of viable organisms with the apical surface of the monolayer and to be dependent upon organism number and duration of infection. Altered transport due to M. pulmonis was not merely a result of epithelial cell death as evidenced by the following: (i) active transport of Na+ and Cl, albeit at reduced rates; (ii) normal cell morphology, including intact tight junctions, as demonstrated by electron microscopy; (iii) maintenance of a mean transepithelial resistance of 440 Ω/cm2; and (iv) lack of leakage of fluid from the basolateral to the apical surface of the monolayer. Alteration in epithelial ion transport in vitro is consistent with impaired pulmonary clearance and altered airway function in M. pulmonis-infected animals. Furthermore, the ability of M. pulmonis to alter transport without killing the host cell may explain its successful parasitism and long-term persistence in the host. Further study of the MTE-M. pulmonis model should elucidate the molecular mechanisms which mediate this reduction in transepithelial ion transport.


Mycoplasmas, the smallest free-living prokaryotes, continue to be a significant cause of respiratory infections in a variety of animals, including humans (44). Their limited biosynthetic capability dictates that these organisms must both colonize and parasitize epithelial cell surfaces. It is therefore surprising that mycoplasmas produce diseases that are slowly progressing and chronic and yet often clinically inconspicuous. The molecular mechanisms responsible for this tenuous truce between the pathogen and the host cell have not yet been identified. Murine respiratory mycoplasmosis, a naturally occurring respiratory disease in laboratory rats and mice caused by Mycoplasma pulmonis (6, 8) and characterized by chronic, often lifelong tracheitis, bronchopneumonia, and bronchiectasis (7, 23, 28), would seem to be an ideal model with which to study these mechanisms. Although M. pulmonis-infected animals generate intense local and systemic immune responses (24, 33, 42, 43), they are incapable of eliminating the organism from the respiratory epithelium. Remodeling of the airways typically observed in infected animals, impairment of pulmonary clearance, and accumulation of mucus (23) suggest that M. pulmonis may compromise the ability of the epithelial cells to absorb and secrete fluid and electrolytes.

Airway epithelial cells possess two major active transport processes, Na+ absorption and Cl section. Water, in turn, osmotically follows the transepithelial movement of these ions, thereby providing a fluid film between the mucus layer and the epithelial cell surface. The depth and composition of this fluid microenvironment must be carefully regulated to allow the exchange of gases and the humidification of the airway epithelium and to ensure proper mucociliary clearance (47, 49). The consequences of impaired fluid and electrolyte transport in the airways are strikingly apparent in cases of cystic fibrosis, a recessive genetic disease resulting from the loss of epithelial chloride channels (31, 48). The studies reported here were designed to determine whether M. pulmonis infection alters electrolyte transport across the murine tracheal epithelium.

The effect of bacteria upon mammalian epithelia in the absence of immune and inflammatory cells can be systematically evaluated by using the Ussing chamber model. Short-circuit current (Isc) studies have helped determine the mechanism by which cholera toxin (18) and other enterotoxins affect the intestinal mucosa (17, 35). Study of various types of epithelial cells by using the Ussing chamber model has also resulted in the identification of numerous microbial substances capable of directly altering the ion transport capacity of the airway epithelium (3, 20, 41).

In the present study, control and M. pulmonis-infected mouse tracheal epithelial cells (MTEs) were evaluated in Ussing chambers. The results clearly show that M. pulmonis infection directly alters epithelial ion transport and that this alteration is species specific, dose and time related, and dependent upon the association of viable organisms with the apical cell surface.

MATERIALS AND METHODS

Mycoplasmas.

Experiments were performed with either a virulent strain of M. pulmonis, CT, originally isolated from a mouse with respiratory mycoplasmosis (14), or with Mycoplasma fermentans incognitus, a mycoplasma of human origin provided by Shyh-Ching Lo at the Armed Forces Institute of Pathology, Washington, D.C. Organisms were grown, harvested, and stored as previously described (46). M. pulmonis was cultured in mycoplasma broth base (Difco) supplemented with heat-inactivated and filtered horse serum (HyClone Laboratories, Logan, Utah) and glucose. After static incubation at 37°C, cultures were divided into 1-ml aliquots and stored at −70°C. Quantitation of mycoplasmas was performed as previously described (1). Specimens were diluted in Hayflick’s broth by serial 10-fold steps (color-changing units [CCU]), and 0.01 ml of each dilution was inoculated in duplicate onto Hayflick’s agar plates (21). The serial dilutions and inoculated plates were incubated at 37°C for 6 to 8 days, and the number of CFU was determined. For quantification of organisms associated with MTEs and demonstration of their growth over time, filters apically inoculated with M. pulmonis for 6 h were washed twice to remove any unadhered organisms and then incubated at 37°C. At 24, 48, 72, and 96 h postinoculation, mycoplasma-infected filters were aseptically removed and vortexed in mycoplasma media, and the number of CFU was determined.

Animals.

Six-week-old CD-1 mice maintained in Trexler-type plastic film isolators were used in these studies. The pathogen-free status of the animals was monitored by culture as previously described (29) for mycoplasmal, viral (Sendai virus, pneumonia virus of mice, polyomavirus, minute virus of mice, ectromelia virus, mouse hepatitis virus, reovirus 3, Theiler’s murine encephalomyelitis virus strain GD VII, lymphocytic choriomeningitis virus, mouse adenovirus, sialodacryadenitis virus, Kilham rat virus, and H-1 virus), fungal, and bacterial pathogens (Charles River Biotechnical Services, Wilmington, Mass.). The animals were also monitored by an enzyme-linked immunosorbent assay for serum antimycoplasmal antibodies (13). The animals were negative for immunoglobulin G and M antimycoplasmal antibodies and were given sterile food and water ad libitum.

Isolation and culture of mouse tracheal epithelial cells.

To study the effect of M. pulmonis on epithelial electrolyte transport, mouse tracheal epithelial cell cultures were prepared as previously described (51, 52). Animals were sacrificed by CO2 inhalation and opened surgically with a ventral midline incision. The intact trachea was aseptically removed from the larynx down to just below the bifurcation. The intact trachea was stripped of remaining connective tissue and cut longitudinally to expose the epithelial cells. Tissues were washed two times with minimal essential medium (MEM; GIBCO/BRL, Grand Island, N.Y.) and placed in solution A (MEM, 1% fetal bovine serum [HyClone Laboratories], 0.1% protease XIV [Sigma Chemical Co., St. Louis, Mo.], 8 U of DNase [Sigma]) at 4°C for 16 to 24 h with intermittent vortexing. Cells were recovered by vigorously vortexing the tracheas in solution A followed by centrifugation at 500 × g for 5 min. The pelleted cells were resuspended in MTE medium, which was made by mixing equal volumes of preconditioned medium (Dulbecco’s MEM [GIBCO/BRL], 10% fetal bovine serum [recollected after feeding a confluent monolayer of 3T3 fibroblasts for 2 days], 1% Pen/Strep [GIBCO/BRL]) and solution B (Ham’s F-12 medium [GIBCO/BRL] with 1 μg of insulin per ml, 7.5 μg of transferrin per ml, 1 μM hydrocortisone, 30 nM 3,3′5-triiodo-l-thyronine sodium, 1 ng of cholera toxin per ml, 2.5 ng of epidermal growth factor per ml, and 10 ng of endothelial cell growth substance per ml [all purchased from Sigma]). The cell suspension was seeded onto porous 0.4-μm-pore-size Transwell support filters (Corning Costar, Cambridge, Mass.) that had been previously coated with type VI collagen (Sigma). MTE medium was added to the outside chamber of each filter, and the filters were incubated at 37°C in the presence of 5% CO2. The basolateral medium was replaced with 0.5 ml of MTE medium three times per week for 2 to 3 weeks. The monolayer confluency was monitored by measuring the ability of the cells to hold back culture medium from their apical surface and by unidirectional [3H]mannitol flux experiments (4, 5). Monolayers were used in experiments 5 to 6 days later. Amiloride and furosemide were purchased from RBI (Natick, Mass.), carbachol was purchased from Sigma, forskolin was obtained from Calbiochem (San Diego, Calif.), and [3H]mannitol was purchased from Dupont NEN (Wilmington, Del.).

Infection of epithelial cell monolayers.

For each experiment, a freshly thawed stock of M. pulmonis was diluted in MTE conditioned medium. Epithelial cells were apically inoculated with 125 μl of medium that contained a total of 0.5 × 107 to 5.0 × 107 CFU of M. pulmonis (4 × 104 to 4 × 105 CFU/μl). For basolateral infection experiments, the basolateral surface of the filters was exposed to 500 μl of medium which contained between 2 × 107 and 2 × 108 CFU of M. pulmonis (4 × 104 to 4 × 105 CFU/μl). Control filters were inoculated with sterile mycoplasma culture medium diluted in MTE conditioned medium at the same ratio. Minion et al. have previously reported that a substantial number of M. pulmonis cells become cell associated within an hour after infection (25). Furthermore, we have also determined that mycoplasma adherence to eukaryotic cells does not increase significantly after 6 to 8 h (unpublished results). As a result of these findings, monolayers were inoculated with mycoplasma culture medium or control medium and incubated at 37°C in the presence of 5% CO2 for 6 h unless otherwise described. After incubation, control and mycoplasma-infected monolayers were washed two times with MTE conditioned medium (125 μl) and then incubated at an air interface for an additional 42 h prior to use in Ussing chambers. Forty-eight hours postinoculation was chosen as the main time point to evaluate transport on the basis of previous studies by Städtlander et al. (39) which showed that an M. pulmonis inoculum of 105 to 107 cells resulted in complete ciliostasis in tracheal organ cultures within 2 to 3 days. In the shorter time course experiments, monolayers were similarily exposed to the control or the mycoplasma inoculum for 6 h, washed, and then incubated at an air interface for an additional 6 or 12 h. We noted that the filters assayed at either 12 or 18 h postinfection had 86.3% lower sodium transport values than those assayed at 48 h. We determined that this decrease was due to the continued presence of the medium on the apical surface of the monolayers prior to their use and that this effect could be reversed if the monolayers were incubated at an air interface for an additional 12 to 24 h. Widdicombe et al. (50) recently reported that the continued presence of culture medium on the apical surface of human tracheal epithelial cells also caused a decline in their transport response and that the incubation of these monolayers again at an air interface resulted in quantitatively normal transport values the following day. We wish to emphasize that all of the experiments reported here were performed in a paired manner; that is, control and experimental filters were prepared, handled, and evaluated in parallel, with cells derived from the same batch of mice.

To determine if mycoplasma-conditioned culture supernatant had a direct effect on ion transport, the inoculum was prepared as described above but was then centrifuged (16,000 × g for 10 min; Eppendorf model 5415C) to pellet the mycoplasma cells. The supernatant was filtered (0.1-μm-pore-size filter; Gelman) to determine that all viable cells had been removed, and it was consistently negative when cultured by both titration and direct inoculation onto agar. For viability studies, control and mycoplasma inocula were UV irradiated with a transilluminator (Photodyne) for 10 min. The effects of these UV-irradiated inocula on transepithelial ion transport were compared to those of control and mycoplasma-containing inocula that had not been exposed to UV light. The number of viable mycoplasmas in all inocula was determined quantitatively (1).

Evaluation of ion transport.

Ussing chamber Isc experiments were performed as previously described (4, 5). After the filter was mounted between the two half-chamber compartments, the apical compartment and then the basolateral compartment were filled with 4.0 ml of prewarmed Ringer’s solution (pH 7.4) composed of 120 mM NaCl, 25 mM NaHCO3, 3.3 mM KH2PO4, 0.83 mM K2HPO4, 1.2 mM CaCl2, and 1.2 mM MgCl2. Glucose (10 mM) was added to the serosal bath, and mannitol (10 mM) was added to the mucosal bathing fluid to eliminate any Na+ current arising from the Na+-glucose cotransporter. Circulation of the solution was accomplished by a gas lift with 95% O2–5% CO2 in both half-chamber compartments, and the temperature was maintained at 37°C by a water jacket. The transmural potential difference (PD) was measured by using 1 M KCl–3% agar bridges. The system was voltage clamped at a zero transmural potential by passing a direct current equal and opposite to the spontaneous PD by using Ag or AgCl electrodes via 1 M KCl–3% agar bridges. The amount of continuous current which is required to nullify the PD is referred to as the Isc and is equal to the sum of all net ionic active-transport processes across the epithelium. The fluid resistance was compensated for prior to the start of the experiment. A 5-mV pulse was applied every 100 s to determine the monolayer resistance, which was calculated by using Ohm’s law and is reported in ohms per square centimeter. Measurements were digitally recorded with the aid of an analog-to-digital converter and saved on a computer hard drive.

The following experimental protocol was utilized to assess the Na+ absorptive and Cl secretory capacity of the uninfected (control) and M. pulmonis-infected monolayers. Under standard culture conditions, the murine respiratory epithelial monolayers are inherently Na+ absorptive. When the MTE filter was mounted in the Ussing chamber, the magnitude of transepithelial Na+ current was determined by adding amiloride (10 μM) to the mucosal bathing solution. The current inhibited by amiloride is referred to hereafter as the amiloride-sensitive Na+ current (INa+). After 10 to 15 min, forskolin (10 μM) was added to both the apical and basolateral surfaces of the monolayer to stimulate cyclic AMP (cAMP)-dependent Cl secretion (IClcAMP). To determine the calcium-mediated Cl current stimulated across the MTE monolayer following pretreatment with amiloride and forskolin, carbachol (100 μM) was added to the basolateral membrane and resulted in a rapid but transient peak in chloride secretion across the monolayer, which is reported in the following experiments as the peak-carbachol current (IClpeak). Since the level of cholinergic-stimulated Cl current was not stable but declined with time, the current which remained 5 min after the addition of carbachol was also measured (IClpeakΔ5). After an additional 15 min, furosemide (10 μM) was added to the basolateral solution to inhibit the Na+-K+-2Cl cotransporter. This abolished any remaining current across the monolayer and ended the experiment.

Electron microscopy.

Preparation of ultrathin sections was performed as previously described (39). Briefly, MTE monolayers were incubated with either M. pulmonis or sterile mycoplasma medium for 6 h at 37°C, washed two times in Dulbecco’s phosphate-buffered saline, and then incubated for an additional 42 h at 37°C. The filters were then prefixed with 1.5% glutaraldehyde for 90 min at 4°C. After the removal of the aldehyde, the filters were washed and stored in phosphate-buffered saline prior to the secondary fixation with 1% osmium tetroxide at room temperature. Dehydration was performed for a graded series of ethanol-water solutions, and specimens were transferred to propylene oxide and embedded in epoxy resin. Ultrathin sections were cut and stained by standard methods and examined as previously described (39).

Statistical analysis.

Results are presented as the means ± standard errors of the means (SEMs). Effects attributable to experimental manipulations were assessed for statistical significance by employing Student’s t test for paired and unpaired data, as appropriate. Experimental treatment effects were considered statistically significant if the probability of a type I error was <0.05 or as otherwise noted.

RESULTS

Inhibition of epithelial ion transport by M. pulmonis.

Strikingly different Isc profiles were observed when control (mock-infected) and M. pulmonis-infected MTEs were evaluated for Na+ absorption and Cl secretion in Ussing chambers (Fig. 1). Prior to the addition of amiloride, the control MTE monolayer mounted in Ussing chambers displayed a resistance of 2,336 Ω/cm2 and an Isc across the monolayer of 27.0 μA/cm2 (Fig. 1A). The addition of amiloride to the apical buffer rapidly reduced the Isc to 7.1 μA/cm2, resulting in the identification of an INa+ of 19.9 μA/cm2. Forskolin caused an increase in the Isc of 11.4 μA/cm2, referred to here as the IClcAMP. Carbachol, a Ca2+-mediated agonist, rapidly increased the Isc to a peak value of 78.6 μA/cm2. Subtraction of the IClcAMP from this total increase resulted in an IClpeak of 67.2 μA/cm2. The IClpeakΔ5 was similarly calculated and found to be 38.6 μA/cm2. After an additional 10 to 15 min, the addition of furosemide to the basolateral solution reduced the Isc to 21.4 μA/cm2, verifying that the Isc was due to net Cl secretion. MTE monolayers that had been infected with M. pulmonis were similarily evaluated and demonstrated a dramatic decrease in transepithelial ion transport (Fig. 1A and D). After monolayers were infected with an initial inoculum of 1.9 × 107 CFU (Fig. 1D), the INa+ was 1.8 μA/cm2, and the IClcAMP, IClpeak, and IClpeakΔ5 values were 4.29, 11.4, and 6.8 μA/cm2, respectively. The results of 13 to 16 additional experiments are summarized in Table 1. In addition, the transepithelial resistance of infected monolayers was also substantially altered. These monolayers displayed a resistance of only 440 ± 87 Ω/cm2 (mean ± SEM). Unidirectional [3H]mannitol flux studies revealed a 2.1-fold-higher flux across M. pulmonis-inoculated monolayers (2.3 ± 0.33 nmol, n = 4) than across control monolayers (1.1 ± 0.21 nmol, n = 4) (P < 0.01). These results are consistent with the 5.4-fold-lower resistance of the M. pulmonis-infected monolayers described above and confirm that M. pulmonis significantly decreases the paracellular resistance of the MTE monolayers. In contrast to the results described above in which the apical surface was infected, paired experiments in which the basolateral surface of the MTEs was exposed to either the control medium or the mycoplasma inoculum (2 × 107 to 2 × 108 CFU, n = 6) were also performed. The Isc values for monolayers exposed basolaterally to the control inoculum included an INa+ of 23.4 ± 2.8 μA/cm2, an IClcAMP of 11.9 ± 1.5 μA/cm2, and an IClpeak of 108.0 ± 12.5 μA/cm2 at 48 h. Prior to the assessment of the transport capacity of the MTE filters that had been basolaterally infected with M. pulmonis, the basolateral feeding medium was cultured to determine the number of CCU of M. pulmonis present. Approximately 106 CCU of M. pulmonis were routinely recovered from the basolaterally infected filters which displayed an INa+ of 24.5 ± 1.7 μA/cm2, an IClcAMP of 11.5 ± 1.6 μA/cm2, and an IClpeak of 118.8 ± 8.2 μA/cm2. These results indicate that exposure of the basolateral surface of the monolayer of M. pulmonis did not alter electrogenic ion transport.

FIG. 1.

FIG. 1

Dose-dependent effect of M. pulmonis on Isc from MTE monolayers. Representative Isc traces showing Na+ and Cl currents in control or M. pulmonis-infected MTE monolayers are presented. (A) Isc trace from medium-inoculated MTE monolayer (control); (B to D) Isc trace from MTE monolayers inoculated with increasing numbers of M. pulmonis cells (1.9 × 106 [B], 6.3 × 106 [C], and 1.9 × 107 [D] CFU). Additions to the Ussing chamber were 10 μM amiloride, mucosal side (a), 10 μM forskolin, mucosal and serosal sides (b), 100 μM carbachol, serosal side (c), and 100 μM furosemide, serosal side (d). Deflections represent the change in current resulting from the ±5-mV pulse, and their values are used to determine the transepithelial resistance.

TABLE 1.

Effect of mycoplasma on MTE epithelial ion transporta

Inoculum (no. of expts) Isc value (μA/cm2)
Resistance (Ω/cm2)
INa+ IClcAMP IClpeak
Hayflick’s medium (control) (n = 16) 35.1 ± 2.8 8.42 ± 1.1 113.1 ± 7.7 2,357 ± 330
M. pulmonis CT (n = 13) 8.7 ± 1.6b 4.4 ± 0.7b 63.1 ± 6.2c 440 ± 87c
SP4 medium (control) (n = 4) 43.1 ± 5.7 21.9 ± 4.3 111.1 ± 25.5 1,257 ± 102
M. fermentans incognitus (n = 6) 34.2 ± 3.8 17.7 ± 2.0 92.2 ± 22.6 1,064 ± 264
a

MTEs were inoculated for 6 h, washed, incubated for an additional 42 h, and assayed for epithelial ion transport as described in Materials and Methods. The data represent the means ± SEMs. 

b

Significantly different from value for control at P of <0.01. 

c

Significantly different from value for control at P of <0.001. 

Altered transport following exposure of the apical surface to M. pulmonis was not merely a result of epithelial cell death, as evidenced by the following: (i) maintenance of a mean transepithelial resistance of 440 Ω/cm2, which is 20 times greater than fluid resistance; (ii) lack of leakage of fluid from the basolateral to the apical surface; and (iii) normal cell morphology, including intact tight junctions, as demonstrated by electron microscopy performed at the time of altered ion transport. Transmission electron micrographs of control MTEs revealed a confluent monolayer of uniform, columnar epithelial cells characterized by tight junctions, microvilli, and a highly convoluted basolateral membrane (data not shown). These characteristics are consistent with the high electrical resistance measured in the Ussing chambers. MTEs examined as late as 48 h after M. pulmonis infection were morphologically identical to the control monolayers (data not shown). Mycoplasmas were not observed in association with the epithelial cells; however, quantitative cultures of infected monolayers documented that the organisms were not only present but also replicating (Table 2). Since the number of epithelial cells comprising the confluent monolayer was estimated to be 3.0 × 105, at 48 h postinoculation, the number of mycoplasmas per cell (i.e., approximately 17) may not be easily detectable by electron microscopy.

TABLE 2.

CFU recovered from MTEs after infection with mycoplasma

Time (h) postinfection CFU recovereda
M. pulmonis CT (n = 4) M. fermentans incognitus (n = 6)
24 (3.0 ± 0.01) × 104 ND
48 (5.1 ± 1.1) × 106 (8.2 ± 2.9) × 105
72 (8.6 ± 3.5) × 106 ND
96 (1.2 ± 1.9) × 107 ND
a

Values are means ± standard errors for numbers of CFU recovered from infected filters 48 h postinfection. ND, not determined. n, numbers of experiments. 

Effect of organism number and duration of exposure.

Increasing the number of M. pulmonis cells in the infecting inoculum resulted in a dose-dependent decrease in both ion transport and transepithelial resistance at 48 h (Fig. 1). The length of exposure of the monolayer to the M. pulmonis inoculum was also varied so that shorter incubation times could be evaluated. Monolayers that were inoculated with M. pulmonis for 1, 3, or 6 h, washed, and immediately assayed displayed a dramatic time-dependent decline in their Isc profile compared to that of the control filters (Fig. 2). The monolayers exposed for 6 h displayed a mean transepithelial resistance of only 53 Ω/cm2, whereas the controls maintained a resistance of 1,571 Ω/cm2. In addition, the infected monolayers did not display Na+ transport and no longer responded to pharmacological stimulators of Cl secretion. Interestingly, 6-h-infected MTEs that were washed and allowed to recover for an additional 18 h displayed resistance values of 1,434 ± 439 Ω/cm2 (n = 10). These values were similar to those of the control MTEs of 1,746 ± 312 Ω/cm2 (n = 14) (Fig. 2).

FIG. 2.

FIG. 2

Acute time-dependent effects of M. pulmonis on transepithelial ion transport and monolayer resistance. A representative series of traces of the Isc profile at 1, 3, 6, or 24 h after exposure of the MTE monolayers to mycoplasma medium (control) or M. pulmonis (2.0 × 107 CFU) is shown. It is important to note the time-dependent decrease in monolayer resistance over 1 to 6 h and the recovery at 24 h. The inhibition of INa+, IClcAMP, and IClpeak were also time dependent but appeared to only partially recover by 24 h.

Viable organisms are required for inhibition of ion transport.

Experiments were performed to determine if inhibition of electrolyte transport was due to a substance released by the mycoplasmas into the medium in which they were grown. MTEs were exposed for 6 h to mycoplasma culture supernatants or uninoculated culture medium. The monolayers were washed and then incubated for an additional 42 h. No differences in Isc values were observed (Fig. 3A). To determine if mycoplasma-conditioned culture medium had an acute affect on ion transport, MTEs were exposed to culture supernatants for 1, 3, and 6 h, washed, and immediately assayed. The ion-transporting capacity of these acutely exposed monolayers was also not statistically different from that of the control monolayers exposed to uninoculated mycoplasma medium for the same intervals (n = 3) (data not shown). These results indicate that altered transport requires interaction with an organism.

FIG. 3.

FIG. 3

Lack of effect of M. pulmonis culture supernatant or UV-irradiated M. pulmonis cells on epithelial ion transport. (A) Monolayers were incubated with either sterile mycoplasma medium (control) or filtered (0.1-μm pore size) supernatant obtained from M. pulmonis stocks for 6 h. Subsequently, the monolayers were washed twice with MTE conditioned medium and incubated for an additional 42 h prior to evaluation in Ussing chambers. Results are the mean Isc values obtained from three experiments ± SEM. (B) Lack of effect of UV-irradiated M. pulmonis cells on epithelial ion transport. Monolayers were exposed to either UV-irradiated sterile mycoplasma medium (control) or a similarly treated M. pulmonis inoculum for 6 h. After incubation, the monolayers were washed twice with MTE conditioned medium and incubated for an additional 42 h in Ussing chambers prior to evaluation. Results are the mean Isc values obtained from five experiments ± SEM.

To determine whether organism viability is also required for alteration of ion transport, MTEs were exposed to either the control or the M. pulmonis inoculum which had been UV irradiated. There was no statistical difference between the epithelial ion transport capacity and the transepithelial resistance of MTEs infected with the UV-irradiated M. pulmonis inoculum (<1% viable organisms remaining) and of those exposed to UV-irradiated uninoculated medium (Fig. 3B). These values were also not different from those of MTE monolayers exposed to unirradiated control inocula (data not shown).

Nonmurine mycoplasma does not affect ion transport.

To determine if the effects of the M. pulmonis inoculum were mycoplasma species specific, a nonmurine mycoplasma was evaluated for its ability to alter transepithelial ion transport by using conditions identical to those described above for M. pulmonis. M. fermentans, a mycoplasma of human origin, was used to inoculate MTEs in numbers ranging from 5 × 105 to up to 60-fold greater than those used for M. pulmonis. M. fermentans had no effect on epithelial transport, despite the recovery of large numbers of M. fermentans from infected filters at 48 h (Table 2). The transepithelial resistance of the M. fermentans-inoculated monolayers was also not significantly different from the controls.

DISCUSSION

Previous in vitro studies have indicated that M. pulmonis can attach to eukaryotic cells within 1 h of exposure (25). The results presented here provide evidence that upon interaction with the respiratory epithelium, M. pulmonis may rapidly alter the electrolyte composition of the fluid layer which lines the airways of its natural host. A 1-h exposure of MTEs to M. pulmonis resulted in a substantial decrease in its ion-transporting capacity and its electrical resistance. As the length of exposure to the inoculum was increased, both transport functions continued to decrease. MTEs inoculated with M. pulmonis for 6 h and then immediately assayed had lost all detectable transport function and almost all transepithelial resistance. Those that were exposed to the inoculum for 6 h, washed, and then incubated for an additional 18 h recovered all of their transepithelial resistance and some of their active-transport capacity. Thus, a 6-h exposure severely compromised the barrier integrity and transport capacity but did not kill the epithelial cells. Several explanations may account for the observed recovery of the monolayer resistance as well as the partial recovery of active transport. The first suggests that the number of organisms associated with the monolayer directly influences its transport capacity. Washing the monolayer after a 6-h exposure to the inoculum may have removed most of the M. pulmonis cells unassociated with the monolayer, thereby allowing it to recover. Forty-eight hours after inoculation, another significant decrease in the resistance of the monolayers occurred. This was again consistent with a measured increase in the number of M. pulmonis cells associated with the monolayer. A second explanation suggests the intriguing possibility that the interaction of M. pulmonis with the monolayer may cause a change in the population of mycoplasma cells. Adherence to the monolayer could induce or select for a less cytopathic population of organisms, allowing the epithelium to survive and reestablish ion transport but at a much reduced level. In these studies, the switching of the organisms from liquid culture media to an air-epithelium interface could trigger a phenotypic change in the cell-associated population. This explanation is consistent with previous studies that have shown that in infected animals M. pulmonis undergoes both phenotypic and genotypic changes which are associated with chronicity (37, 45). In contrast to the transepithelial resistance, when the monolayer’s capacity for Na+ absorption or Cl secretion was inhibited, transport of neither pathway returned to control levels. These results suggest that the decrease in transepithelial resistance and the inhibition of electrogenic ion transport by M. pulmonis may be independently mediated.

Together, these studies indicate that the addition of M. pulmonis to the apical surface of MTEs rapidly alters both epithelial barrier integrity and transport function. The failure of M. pulmonis to affect ion transport from the basolateral side reinforces the importance of interaction with the apical surface and is consistent with in vivo studies of mice which suggest that M. pulmonis remains limited to the apical surface, i.e., it is rarely found in the submucosa (39). The epithelial cells were grown on a 0.4-μm-pore-size filter, and it is possible that the filter precluded the interaction of the mycoplasmas with the basolateral cell surface despite their small cellular size (180 to 300 nm) and their plasticity associated with the lack of a cell wall (44). M. pulmonis cells (106/ml) were recovered from the basolateral medium after a 48-h incubation, indicating that their presence on the basolateral side was insufficient to alter transport. We were unsuccessful in our attempts to grow MTEs on a more porous support (4.0-μm pore size) to test further whether MTE-M. pulmonis contact at the basolateral membrane would alter transport.

Other investigators have previously shown that M. fermentans, a mycoplasma of human origin, does not cause cytopathic effects in mice following intranasal inoculation or in murine tracheal organ cultures (40). Consistent with these results, ion transport was also not altered when the MTE monolayers were infected with M. fermentans, despite the large numbers of M. fermentans cells recovered from the monolayers at 48 h postinfection. Thus, the presence of mycoplasma cells per se does not lead to the alterations observed in the MTEs but rather suggests that a species-specific interaction between M. pulmonis and the MTE monolayer would seem to be required. To verify this, additional species of mycoplasma must be studied in the MTE monolayer system.

Although several potential pathogenic factors have been identified in the mycoplasmas, including peroxidases (10), endonucleases (30, 32), phospholipases (16, 34), and a membrane-associated hemolytic activity (10, 27), the molecular mechanisms by which M. pulmonis colonizes the respiratory epithelium and establishes chronic airway disease are unknown. Exposure of the monolayers to M. pulmonis culture supernatants did not alter Na+ absorption, Cl secretion, or the resistance of the MTEs. These results indicate that the M. pulmonis component responsible for the alterations in electrogenic ion transport and the decrease in epithelial resistance of the MTE monolayer is not released by M. pulmonis cells under normal laboratory culture conditions but requires the intact organism. Additional studies will be needed, however, to determine if the inhibiting activity is selectively secreted by mycoplasma cells upon contact with the epithelium. Several studies have examined the pathogenic potential of purified mycoplasma membranes, cell lysates, and nonviable organisms (2, 12, 19, 26). In our studies, M. pulmonis cells that were killed by UV treatment were no longer able to inhibit the absorption or secretion of ions or to decrease the transepithelial resistance of the monolayer.

Numerous researchers have reported that the infection of tracheal organ cultures with mycoplasmas results in ciliostasis, loss of tight junctions, and in most cases the complete exfoliation of the respiratory epithelium (2, 9, 11, 15, 24, 39). This study, in contrast, evaluated the electrogenic ion transport capacity of MTEs infected with M. pulmonis and reveals that this organism causes much more subtle changes in the respiratory epithelium than have previously been observed by other investigators. The inhibition of Na+ absorption and Cl secretion and the concomitant loss in resistance of the epithelial monolayer suggest that M. pulmonis infection leads to the formation of a new functional steady state in which the monolayer continues to absorb and secrete fluid and electrolytes but at a much reduced level. The pathophysiological consequences of this reduced functional state are a change in the volume and composition of the fluid which bathes the airways. This could, in turn, compromise ciliary movement and mucus hydration and ultimately lead to a reduction in mucociliary clearance.

Ion transport across the epithelial monolayer is a highly complex and tightly regulated molecular cross talk between extracellular signals, intracellular second messengers, and the transport proteins in the apical and basolateral cell membranes. Therefore, the modulation of ion transport and transepithelial resistance by M. pulmonis could occur at a variety of sites. The absorption and secretion of fluid and electrolytes across the respiratory epithelium involve the coordinated movement of ions across the apical and basolateral membranes through highly selective Na+, Cl, and K+ channels, the Na+-K+ pump, and the Na+-K+-2Cl cotransporter, any of which could be directly or indirectly affected during mycoplasmal infection. The ability of M. pulmonis to alter host cell second messengers is a logical explanation for the observed decrease in both Na+ and Cl transport; however, the factors mediating these alterations have yet to be clearly addressed for any mycoplasma species (36). Both Na+ and Cl were inhibited in our studies, suggesting that M. pulmonis may alter a single step which is central to both pathways (e.g., the basolateral K+ channel). This notion is supported by the recent studies of Izutsu et al., who showed that Mycoplasma orale infection affects the expression and regulation of K+ channels in the surface membrane of a human submandibular gland cell line (22).

Recent studies by Smith et al. (38) indicate that pathogenic microorganisms may persist in the airways of patients with cystic fibrosis because bacteriocidal factors normally produced by the respiratory epithelium are inactivated by abnormal salt concentrations. Our results suggest that the ability of M. pulmonis to alter transepithelial ion transport may allow it to escape killing by a similar mechanism. This is further supported by the fact that M. pulmonis-infected animals are incapable of clearing the organism from the respiratory epithelium and are also highly susceptible to secondary infections. It is safe to assume that the pathophysiology which underlies chronic mycoplasmal infections is undoubtedly complex and multifactorial in origin. The methodologies described herein may be useful in determining which pathogenic factors are involved and, in turn, guide us toward the most logical approach for therapy against persistent mycoplasmal diseases.

ACKNOWLEDGMENTS

We are greatly indebted to Eugene Arms, Jeff Ervin, and Darin Steele for excellent technical assistance. We thank Dan Devor and Bruce Schultz for their helpful discussions.

This work was supported in part by grant AI 33197 to G.H.C. from the National Institute of Allergy and Infectious Disease and grant DK 45970 to R.J.B. from the National Institute of Diabetes and Digestive and Kidney Diseases. R.J.B. is a Cystic Fibrosis Foundation Research Scholar. L.C.L. was supported by training grant 732 HL 07553 to G.H.C. from the National Heart, Lung, and Blood Institute.

REFERENCES

  • 1.Albers A C, Fletcher R D. Simple method for quantitation of viable mycoplasmas. Appl Environ Microbiol. 1982;43:958–960. doi: 10.1128/aem.43.4.958-960.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Araake M. Comparison of ciliostasis by mycoplasmas in mouse and chicken tracheal organ cultures. Microbiol Immunol. 1982;26:1–14. doi: 10.1111/j.1348-0421.1982.tb00148.x. [DOI] [PubMed] [Google Scholar]
  • 3.Ball J M, Tian P, Zeng C Q-Y, Morris A P, Estes M K. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science. 1996;272:101–104. doi: 10.1126/science.272.5258.101. [DOI] [PubMed] [Google Scholar]
  • 4.Bridges R J, Nell G, Rummel W. Influence of vasopressin and calcium on electrolyte transport across isolated colonic mucosa of the rat. J Physiol. 1983;338:463–475. doi: 10.1113/jphysiol.1983.sp014684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bridges R J, Rummel W, Wollenberg P. Effects of vasopressin on electrolyte transport across isolated colon from normal and dexamethasone-treated rats. J Physiol. 1984;355:11–23. doi: 10.1113/jphysiol.1984.sp015402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cassell G H, Davis J K, Wilborn W H, Wise K S. Pathobiology of mycoplasmas. In: Schlessinger D, editor. Microbiology—1978. Washington, D.C: American Society for Microbiology; 1978. pp. 399–403. [Google Scholar]
  • 7.Cassell G H, Hill A. Murine and other small animal mycoplasmas. In: Tully J G, Whitcomb R F, editors. The mycoplasmas. II. New York, N.Y: Academic Press, Inc.; 1979. pp. 235–273. [Google Scholar]
  • 8.Cassell G H, Clyde W A, Jr, Davis J K. Mycoplasmal respiratory infections. In: Barile M F, Razin S, Tully J G, Whitcomb R F, editors. The mycoplasmas. IV. New York, N.Y: Academic Press, Inc.; 1985. pp. 69–106. [Google Scholar]
  • 9.Cherry J D, Taylor-Robinson D. Growth and pathogenesis of Mycoplasma mycoides var. capri in chicken embryo tracheal organ cultures. Infect Immun. 1970;2:431–438. doi: 10.1128/iai.2.4.431-438.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cole B C, Ward J R, Martin C H. Hemolysin and peroxide activity of mycoplasma species. J Bacteriol. 1968;95:2022–2030. doi: 10.1128/jb.95.6.2022-2030.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Collier A M, Clyde W A, Jr, Denny F W. Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture (34385) Proc Soc Exp Biol Med. 1969;132:1153–1158. doi: 10.3181/00379727-132-34385. [DOI] [PubMed] [Google Scholar]
  • 12.Davidson M K, Davis J K, Lindsey J R, Cassell G H. Clearance of different strains of Mycoplasma pulmonis from the respiratory tract of C3H/HeN mice. Infect Immun. 1988;56:2163–2168. doi: 10.1128/iai.56.8.2163-2168.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Davis J K, Simecka J W, Williamson J S P, Ross S E, Juliana M M, Thorpe R B, Cassell G H. Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences. Infect Immun. 1985;49:152–158. doi: 10.1128/iai.49.1.152-158.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Davis J K, Thorpe R B, Parker R F, White H, Dziedzic D, D’Arcy J, Cassell G H. Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect Immun. 1986;54:194–201. doi: 10.1128/iai.54.1.194-201.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.DeBey M, Ross R F. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumonia in porcine tracheal organ cultures. Infect Immun. 1994;62:5312–5318. doi: 10.1128/iai.62.12.5312-5318.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.De Silva N S, Quinn P A. Localization of endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J Clin Microbiol. 1991;29:1493–1503. doi: 10.1128/jcm.29.7.1498-1503.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Fasano A, Kay B A, Russell R G, Maneval D R, Jr, Levine M M. Enterotoxin and cytotoxin production by enteroinvasive Escherichia coli. Infect Immun. 1990;58:3717–3723. doi: 10.1128/iai.58.11.3717-3723.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Field M, Fromm D, Al-Awqati Q, Greenough W B., III Effect of cholera enterotoxin on ion transport across ileal mucosa. J Clin Invest. 1972;51:796–804. doi: 10.1172/JCI106874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gaybridge M G, Johnson C K, Cameron A M. Cytotoxicity of Mycoplasma pneumoniae membranes. Infect Immun. 1974;10:1127–1134. doi: 10.1128/iai.10.5.1127-1134.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Graham A, Steel D M, Wilson R, Cole P J, Alton E W F W, Geddes D M. Effects of purified pseudomonas rhamnolipids on bioelectric properties of sheep tracheal epithelium. Exp Lung Res. 1993;19:77–89. doi: 10.3109/01902149309071082. [DOI] [PubMed] [Google Scholar]
  • 21.Hayflick, L. 1965. Tissue cultures and mycoplasmas. Tex. Rep. Biol. Med. 23(Suppl. 1):285–303. [PubMed]
  • 22.Izutsu K T, Fatherazi S, Belton C M, Oda D, Cartwright F D, Kenny G E. Mycoplasma orale infection affects K+ and Cl− currents in the HSG salivary gland cell line. In Vitro Cell Dev Biol. 1996;32:361–365. doi: 10.1007/BF02722962. [DOI] [PubMed] [Google Scholar]
  • 23.Lindsey J R, Baker H J, Overcash R G, Cassell G H, Hunt C E. Murine chronic respiratory disease. Significance as a research complication and experimental production with M. pulmonis. Am J Pathol. 1971;64:675–716. [PMC free article] [PubMed] [Google Scholar]
  • 24.Lindsey J R, Cassell G H. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol. 1973;72:63–90. [PMC free article] [PubMed] [Google Scholar]
  • 25.Minion F C, Cassell G H, Pnini S, Kahane I. Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination. Infect Immun. 1984;44:394–400. doi: 10.1128/iai.44.2.394-400.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Minion F C, Goguen J D. Identification and preliminary characterization of external membrane-bound nuclease activity in Mycoplasma pulmonis. Infect Immun. 1986;51:352–354. doi: 10.1128/iai.51.1.352-354.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Minion F C, Jarvill-Taylor K. Membrane-associated hemolysin activities in mycoplasmas. FEMS Microbiol Lett. 1994;116:101–106. doi: 10.1111/j.1574-6968.1994.tb06682.x. [DOI] [PubMed] [Google Scholar]
  • 28.Organick A B, Siegesmund K A, Lutsky I I. Pneumonia due to Mycoplasma in gnotobiotic rats. II. Localization of Mycoplasma pulmonis in the lungs of infected gnotobiotic mice by electron microscopy. J Bacteriol. 1966;92:1164–1176. doi: 10.1128/jb.92.4.1164-1176.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Parker R F, Davis J K, Blalock D K, Thorp R B, Simecka J W, Cassell G H. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect Immun. 1987;55:2631–2635. doi: 10.1128/iai.55.11.2631-2635.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pollak J D, Hoffman P J. Properties of the nucleases of mollicutes. J Bacteriol. 1982;152:538–541. doi: 10.1128/jb.152.1.538-541.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Quinton P M. Defective epithelial ion transport in cystic fibrosis. Clin Chem. 1989;35:726–730. [PubMed] [Google Scholar]
  • 32.Razin S, Knyszynski A, Lifschitz Y. Nucleases of mycoplasma. J Gen Microbiol. 1964;36:323–332. doi: 10.1099/00221287-36-2-323. [DOI] [PubMed] [Google Scholar]
  • 33.Ross S E, Simecka J W, Gambill G P, Davis J K, Cassell G H. Mycoplasma pulmonis possesses a novel chemoattractant for B lymphocytes. Infect Immun. 1992;60:669–674. doi: 10.1128/iai.60.2.669-674.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Salaman M, Rottem S. The cell membrane of Mycoplasma penetrans: lipid composition and phospholipase A1 activity. Biochim Biophys Acta. 1995;1235:369–377. doi: 10.1016/0005-2736(95)80026-c. [DOI] [PubMed] [Google Scholar]
  • 35.Savarino S J, Fasano A, Robertson D C, Levine M M. Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest. 1991;87:1450–1455. doi: 10.1172/JCI115151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Simecka J W, Davis J K, Davidson M K, Ross S E, Städtlander C T K-H, Cassell G H. Mycoplasma diseases of animals. In: Maniloff J, McElhaney R N, Finch L R, Baseman J B, editors. Mycoplasmas: molecular biology and pathogenesis. Washington, D.C: American Society for Microbiology; 1992. pp. 391–415. [Google Scholar]
  • 37.Simmons W, Cao Z, Glass J, Watson H L, Cassell G H. Comparison of the V-1 genes from two Mycoplasma pulmonis variants that differ with respect to disease potential. IOM Lett. 1994;3:557–558. [Google Scholar]
  • 38.Smith J J, Travis S M, Greenberg E P, Welsh M J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 1996;85:229–236. doi: 10.1016/s0092-8674(00)81099-5. [DOI] [PubMed] [Google Scholar]
  • 39.Städtlander C T K-H, Watson H L, Simecka J W, Cassell G H. Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro. Infect Immun. 1991;59:4201–4211. doi: 10.1128/iai.59.11.4201-4211.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Städtlander, C. T. K.-H., H. L. Watson, J. W. Simecka, and G. H. Cassell. 1993. Cytopathogenicity of Mycoplasma fermentans (including strain incognitus). Clin. Infect. Dis. 17(Suppl. 1):S289–S301. [DOI] [PubMed]
  • 41.Stutts M J, Schwab J H, Chen M G, Knowles M R, Boucher R C. Effects of Pseudomonas aeruginosa on bronchial epithelial ion transport. Am Rev Respir Dis. 1986;134:17–21. doi: 10.1164/arrd.1986.134.1.17. [DOI] [PubMed] [Google Scholar]
  • 42.Taylor G, Taylor-Robinson D. Humoral and cell-mediated immune mechanisms in mycoplasma infections. Colloq INSERM. 1974;33:331–336. [Google Scholar]
  • 43.Taylor-Robinson D, Schorlemmer H U, Furr P M, Allison A C. Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms. Clin Exp Immunol. 1978;33:486–494. [PMC free article] [PubMed] [Google Scholar]
  • 44.Tully J G, Whitcomb R F, editors. The mycoplasmas. II. Human and animal mycoplasmas. New York, N.Y: Academic Press, Inc.; 1979. p. 509. [Google Scholar]
  • 45.Watson H L, McDaniel L S, Blalock D K, Fallon M T, Cassell G H. Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis. Infect Immun. 1988;56:1358–1365. doi: 10.1128/iai.56.5.1358-1363.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Watson H L, Blalock D K, Cassell G H. Relationship of hydrophobicity of the V-1 antigen of Mycoplasma pulmonis to adherence. Zentralbl Bakteriol Suppl. 1990;20:650–654. [Google Scholar]
  • 47.Welsh M J. Electrolyte transport by airway epithelia. Physiol Rev. 1987;67:1143–1184. doi: 10.1152/physrev.1987.67.4.1143. [DOI] [PubMed] [Google Scholar]
  • 48.Widdicombe J H. Altered chloride transport of tracheal epithelium in cystic fibrosis. Prog Clin Biol Res. 1987;254:115–126. [PubMed] [Google Scholar]
  • 49.Widdicombe J H, Miller S S, Finkbeiner W E. Altered regulation of airway fluid content in cystic fibrosis. In: Dodge J A, Brock D J H, Widdicombe J H, editors. Cystic fibrosis: current topics. Vol. 2. New York, N.Y: John Wiley & Sons, Inc.; 1994. pp. 109–129. [Google Scholar]
  • 50.Widdicombe J H, Azizi F, Kang T, Pittet J F. Transient permeabilization of airway epithelium by mucosal water. J Appl Physiol. 1996;81:491–499. doi: 10.1152/jappl.1996.81.1.491. [DOI] [PubMed] [Google Scholar]
  • 51.Wu R, Groelke J W, Chang L Y, Proter M E, Smith D, Nettesheim P. Effects of hormones on the multiplication and differentiation of tracheal epithelial cells in culture. In: Sirbasku D, et al., editors. Growth of cells in hormonally defined media. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press; 1982. pp. 641–656. [Google Scholar]
  • 52.Wu R, Yankaskas J, Cheng E, Knowles M R, Boucher R. Growth and differentiation of human nasal epithelial cells in culture. Am Rev Respir Dis. 1985;132:311–320. doi: 10.1164/arrd.1985.132.2.311. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES